CN1238007C - 金银灵芝茶及其制备方法 - Google Patents
金银灵芝茶及其制备方法 Download PDFInfo
- Publication number
- CN1238007C CN1238007C CN 02102121 CN02102121A CN1238007C CN 1238007 C CN1238007 C CN 1238007C CN 02102121 CN02102121 CN 02102121 CN 02102121 A CN02102121 A CN 02102121A CN 1238007 C CN1238007 C CN 1238007C
- Authority
- CN
- China
- Prior art keywords
- honeysuckle
- tea
- ganoderma tea
- maifanitum
- glossy ganoderma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000222336 Ganoderma Species 0.000 title claims abstract description 27
- 238000000034 method Methods 0.000 title claims description 11
- 241001122767 Theaceae Species 0.000 title description 22
- 230000008569 process Effects 0.000 title description 7
- 239000003814 drug Substances 0.000 claims abstract description 15
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 13
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 13
- 235000012907 honey Nutrition 0.000 claims abstract description 4
- 244000269722 Thea sinensis Species 0.000 claims abstract 11
- 240000008397 Ganoderma lucidum Species 0.000 claims description 21
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 21
- 241000628997 Flos Species 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 241000218628 Ginkgo Species 0.000 claims description 12
- 238000005303 weighing Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 6
- 239000012634 fragment Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000003708 ampul Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000000084 colloidal system Substances 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 239000007938 effervescent tablet Substances 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000013035 low temperature curing Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 241000411851 herbal medicine Species 0.000 abstract description 10
- 206010028980 Neoplasm Diseases 0.000 abstract description 7
- 201000011510 cancer Diseases 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 7
- 206010020772 Hypertension Diseases 0.000 abstract description 6
- 208000029078 coronary artery disease Diseases 0.000 abstract description 6
- 235000019640 taste Nutrition 0.000 abstract description 6
- 208000006673 asthma Diseases 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 4
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 abstract description 3
- 208000024827 Alzheimer disease Diseases 0.000 abstract description 3
- 206010039966 Senile dementia Diseases 0.000 abstract description 3
- 230000032683 aging Effects 0.000 abstract description 3
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 3
- 230000035622 drinking Effects 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 208000012895 Gastric disease Diseases 0.000 abstract description 2
- 208000034189 Sclerosis Diseases 0.000 abstract description 2
- 230000001835 salubrious effect Effects 0.000 abstract description 2
- 208000018556 stomach disease Diseases 0.000 abstract description 2
- 208000011580 syndromic disease Diseases 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 5
- 230000002265 prevention Effects 0.000 abstract 2
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 238000009098 adjuvant therapy Methods 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 208000016253 exhaustion Diseases 0.000 abstract 1
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract 1
- 239000004575 stone Substances 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 208000031226 Hyperlipidaemia Diseases 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 229930182486 flavonoid glycoside Natural products 0.000 description 4
- 150000007955 flavonoid glycosides Chemical class 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 206010013911 Dysgeusia Diseases 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 235000013409 condiments Nutrition 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 2
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 2
- DANYIYRPLHHOCZ-UHFFFAOYSA-N 5,7-dihydroxy-4'-methoxyflavone Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 DANYIYRPLHHOCZ-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010006458 Bronchitis chronic Diseases 0.000 description 2
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001088 anti-asthma Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000007451 chronic bronchitis Diseases 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 2
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- -1 sheet Substances 0.000 description 2
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- CPGCVOVWHCWVTP-LJAQVGFWSA-N (S)-nonacosan-10-ol Chemical compound CCCCCCCCCCCCCCCCCCC[C@@H](O)CCCCCCCCC CPGCVOVWHCWVTP-LJAQVGFWSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000371997 Eriocheir sinensis Species 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 244000064622 Physalis edulis Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000009962 acacetin Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- CPGCVOVWHCWVTP-UHFFFAOYSA-N celidoniol Natural products CCCCCCCCCCCCCCCCCCCC(O)CCCCCCCCC CPGCVOVWHCWVTP-UHFFFAOYSA-N 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种金银灵芝茶及其制备方法,是由灵芝草、金银花、银杏叶、麦饭石等10种天然中草药和蜂蜜、糖组成,经炮制组合加工制成。本发明组方巧妙合理科学,配伍精当,剂量恰到好处,既保留了灵芝草等药物的有效成份,且茶色金黄明亮悦目,口感清爽,回味醇美,是男女老幼四季皆宜的饮用佳品。对防癌、抗癌、延缓衰老、高血压、高血脂、脑血管硬化症、糖尿病、冠心病、哮喘、胃病、老年痴呆症、疲劳综合症等也有良好的预防和辅助治疗作用。
Description
本发明属于保健食品领域,涉及一种金银灵芝茶及其制备方法。
灵芝草,古称“仙草”有起死回生之功,《白蛇传》里的白素贞舍身盗灵芝草救许仙的感人故事,更为灵芝草增加了神秘色彩。据医书记载,灵芝草味淡、微苦、温,归肝、肺、心经。现代科学技术测试灵芝草含有麦角甾醇,有机酸,氨基酸,葡萄糖,树脂,甘露醇,多糖类,脂肪酸;又含生物碱,内醇,香豆精,水溶性蛋白质和多种酶类。具有滋养强壮,安神平喘作用。主治头晕失眠、神经衰弱、高血压病、冠心病、高血脂症、肝炎、慢性支气管炎、矽肺、哮喘、风湿性关节炎、消化不良、虚劳等,以及明显的提高人体免疫力,防癌抗癌,抗衰老作用。因此,灵芝草是古今中外都普遍推崇的良药,应用面很广泛。由于灵芝草具有以上所述的独特作用,若将灵芝草开发为保健食品,则应用更为广泛,效益更好。但是单味灵芝草存在着味苦,口味不佳等弊端。
本发明的目的是克服单味灵芝草的不足,根据中医“君臣佐使”的组方原则,开发提供一种保健功效确切显著,服法简便,色味俱佳的金银灵芝茶及其制备方法。
本发明由主药和佐料构成。
主药:灵芝草、金银花、银杏叶、麦饭石、橘皮、枸杞子、菊花、薄荷、大枣、甘草。
佐料:蜂蜜、糖等。
本发明的制备方法是:
1、配方比例(重量):
主药:
灵芝草 31.59% 金银花 10.52% 银杏叶 10.52%
麦饭石 10.52% 橘 皮 5.26% 枸杞子 5.26%
菊 花 5.26% 薄 荷 10.52% 大 枣 7.90%
甘 草 2.65%
以上主药总重量比为百分之百。
2、佐料:蜂蜜、糖适量。
3、将以上所述10种中草药炮制合格,称量配齐,低温烘、焙或晾干,切丝、制片、粉碎,混合均匀后包装成袋泡茶,每个袋泡茶重1~2g。
4、将以上所述10种中草药炮制合格,称量配齐,切成碎块,加50%乙醇浸泡3小时后,加热回流提取3次,每次1小时,合并滤液,减压回收乙醇,浓缩成稠膏,真空干燥成干浸膏,再以干浸膏和消毒过的水勾兑成瓶装茶水,每瓶装100~500ml。或将干浸膏与适量泡腾崩解物料用医药加工器械制成泡腾片。
5、将以上所述10种中草药炮制合格,称量配齐,切成碎块,加入适量水共置于容器内,用文火熬制3个小时后,将药液取出,静置沉淀、过滤、消毒,和适量蜂蜜、糖制配成口服液,瓶或安瓿装。
6、将以上所述10种中草药炮制合格,称量配齐,低温烘、焙或晾干,利用气流粉碎器、流能磨或胶体磨将上述药物粉碎成φ1~5μm的微粉,用医药加工器械制成胶囊、片、丸。
本发明组方中有关药物成分主要功能与配制。
本发明所述的金银灵芝茶中的灵芝草:味淡、微苦、温,入肝、肺、心经。含麦角甾醇,有机酸,氨基酸,葡萄糖,树脂,甘露醇,多糖类,脂肪酸;又含生物碱,内醇,香豆精,水溶性蛋白质和多种酶类。具有滋养强壮、安神平喘作用。主治头晕失眠、神经衰弱、高血压病、冠心病、高血脂症、肝炎、慢性支气管炎、矽肺、哮喘、风湿性关节炎、消化不良、虚劳等,以及明显的提高人体免疫力、防癌抗癌、抗衰老作用。
本发明所述的金银灵芝茶中的金银花:甘、寒,入肺、胃经。含木犀草素,肌醇,皂甙,鞣质等。清热解毒。主治温病发热、热毒血痢、痈疡、肿毒、瘰疠、痔瘘。
本发明所述的金银灵芝茶中的银杏叶(别名白果叶):甘苦涩、平。含白果醇,异鼠李素,山奈酚,芸香甙,白果双黄酮,白果苦内脂,黄酮甙等。益心敛肺、化湿止泻、降血压、降血脂、降胆固醇。治胸闷心痛,心悸怔忡、痰喘咳嗽、泻痢、白带,对高血压、高血脂、脑动脉硬化症、冠心病等心脑血管病有良好的预防治疗作用。
本发明所述的金银灵芝茶中的麦饭石:甘、温、无毒。含锶、钙、镁、钾、铁、铜、锌等二十余种微量元素。治痈疽发背。
本发明所述的金银灵芝茶中的橘皮(别名陈皮):辛、苦、温,入脾、肺、肝、胃经。含挥发油,主要为柠檬烯、枸椽醛,另含橙皮甙,胡罗卜素,隐黄素,维生素C,维生素B1和果胶等。理气、调中、燥湿、化痰。治胸腹胀满、不思饮食、呕吐哕逆、咳嗽痰多,亦解鱼、蟹毒。
本发明所述的金银灵芝茶中的枸杞子:甘、平,入肝、肾经。含甜菜碱,胡萝卜素,核黄素,脂肪油,烟酸,维生素A、C,酸浆红素,钙、磷、铁,另含多种游离氨基酸:白氨酸、缬氨酸、脯氨酸、丙氨酸,酪氨酸、谷酰胺、甘氨酸、天冬氨酸、天冬酰胺和组氨酸等。滋肾润肺,养肝明目。主治肝肾阴虚、腰膝酸软、目昏多泪、虚劳咳嗽、消渴、遗精。
本发明所述的金银灵芝茶中的菊花:甘、苦、微寒,入肺、肝经。含腺嘌呤,氨基酸,菊甙,胆碱,黄酮类和挥发油。此外,尚含有微量维生素A样物质、维生素B1、刺槐素等。散风、清热、明目、解毒。主治风热头痛、目眩、目赤、疔疮、肿毒、痈疽。
本发明所述的金银灵芝茶中的薄荷:辛、凉,入肺、肝经。含挥发油(为薄荷脑、薄荷酮、还有醋酸薄荷脂及其他萜稀类化合物),树脂及少量鞣质,迷选香酸。清风、散热、辟秽、解毒。主治外感风寒、头痛目赤,咽喉肿痛、口疮、牙痛、皮肤瘾疹。
本发明所述的金银灵芝茶中的大枣:甘、温,入脾、胃经。含蛋白质,糖类,有机酸,粘液汁,维生素A、B2、C,微量钙、铁、磷等。补脾和胃、益气生津、调营卫,解药毒。主治胃虚食少,脾弱便溏,气血津液不足,营卫不和,心悸怔忡、妇人脏燥。
本发明所述的金银灵芝茶中的甘草:甘、平,入心、肺、胃、脾经。含甘草甜素(是甘草酸的钾、钙属皂甙类),甘草甙(属黄酮甙),甘草甙元,异甘草甙,异甘草甙元,甘露醇B-固甾醇,糖类,有机酸等。黄酮甙对改善血液循环,增强身体抵抗力、促进胃组织新生,都有良好的作用。补脾胃,抗溃疡,镇惊止痛,抗炎抗菌,保护肝细胞,抗病毒,和中缓急,润肺,解毒,调和诸药。治脾胃虚弱,食少,腹疼便溏,劳倦发热,肺痿咳嗽,心悸、惊痫,咽喉肿痛,消化性溃疡,痈疽疮疡,解药毒及食物中毒。
上述本发明中的10种中草药,根据中医君臣佐使组方原则,通过炮制,以及组合加工制剂,产生一系列理化和生化反应,并通过药物成分间的协同作用,从而产生了良好的口感、茶色和功效。本发明组方巧妙合理科学,配伍精当,剂量恰到好处,无毒无副作用,既保留了灵芝草等药物的有效成份,且茶色金黄明亮悦目,口感清爽,回味醇美。经现代科学技术分析检验,含有多种微量元素、氨基酸、挥发油、酶类及丰富的水溶性蛋白质、黄酮甙、维生素等。具有清热解毒、健脑明目、活血化瘀、滋补养颜、养血安神,补肝益肾、健脾和胃、延年益寿之功效。能增强人体免疫能力、抗疲劳、抗癌防癌、护肤养颜、健脾和胃、延缓衰老;同时对改善心脑血管血液循环、防止心脑血管老化、促进健康和智力发育有良好的作用。是心脑血管硬化症、高血脂、高血压、冠心病、糖尿病、癌症、老年痴呆症患者及消化不良,饮酒过量人的理想天然饮品。也适用于男女老幼四季饮用。达到了功效确切、服法简便,色味俱佳的目的。
下面以最佳实施例说明本发明。
1、配方及重量:
灵芝草 300-360g 金银花 100-120g 银杏叶 100-120g
麦饭石 100-120g 橘 皮 50-60g 枸杞子 50-60g
菊 花 50-60g 薄 荷 100-120g 大 枣 75-90g
甘 草 25-30g
2、蜂蜜、糖适量。
3、将以上所述10种中草药炮制合格,称量配齐,低温烘、焙或晾干,切丝、制片、粉碎,混合均匀后包装成袋泡茶,装茶后每小袋重1.5g,一次1-2袋,用开水冲泡,有效成份即可渗出,三分钟后即可饮用,茶色金黄明亮悦目,口感清爽,回味醇美。
4、将以上所述10种中草药炮制合格,称量配齐,切成碎块,加50%乙醇浸泡3小时后,加热回流提取3次,每次1小时,合并滤液,减压回收乙醇,浓缩成稠膏,真空干燥成干浸膏和消毒过的水勾兑成瓶装茶水,每瓶装100-500ml,随意饮用。或将干浸膏与适量泡腾崩解物料用医药加工器械制成泡腾片。
5、将以上所述10种中草药炮制合格,称量配齐,切成碎块,加入适量水共置于容器内用文火熬制3个小时后,将药液取出,静置沉淀,过滤,消毒,和适量蜂蜜、糖配制成口服液,瓶或安瓿装。瓶装每瓶100-500ml,安瓿装每支10-15ml。一次服用10-15ml,一日3-5次。
6、将以上所述的10种中草药炮制合格,称量配齐,低温烘焙或晾干,利用气流粉碎器、流能磨或胶体磨将上述药物粉碎成φ1-5μm的微粉,用医药加工器械制成胶囊或片、丸。每次服2-3粒(片),每日三次。
金银灵芝茶是绿色天然珍品新茶,顺应了现代社会人们追求自然,回归自然的历史潮流,并且以其独特的保健功效,清爽的口感,醇美的回味,为人们的生活增添了新的享受。饮用金银灵芝茶是身份的象征,健康长寿的需求,时代的潮流。
高血脂、高血压、脑动脉硬化症、糖尿病、冠心病、哮喘、胃病、癌症、老年痴呆症、疲劳综合症等是现代社会的文明病、高发多发病,常饮金银灵芝茶对上述病症有良好的预防和辅助治疗作用。因此,也会为人类健康做出贡献,社会效益巨大。
金银灵芝茶也适应于男女老幼四季饮用,是人们日常生活中的理想饮品和馈赠佳品。
Claims (5)
1、一种金银灵芝茶,其特征在于由灵芝草、金银花、银杏叶、麦饭石、橘皮、枸杞子、菊花、薄荷、大枣、甘草组成,重量百分比为灵芝草31.59%、金银花10.52%、银杏叶10.52%、麦饭石10.52%、橘皮5.26%、枸杞子5.26%、菊花5.26%、薄菏10.52%、大枣7.90%、甘草2.65%,上述总重量比为百分之百。
2、一种制备如权利要求1所述的金银灵芝茶的方法,其特征在于将灵芝草31.59%、金银花10.52%、银杏叶10.52%、麦饭石10.52%、橘皮5.26%、枸杞子5.26%、菊花5.26%、薄菏10.52%、大枣7.90%、甘草2.65%,按总重量比为百分之百称量配齐,低温烘焙或晾干,切丝、制片、粉碎,混合均匀后包装成袋泡茶,每个袋泡茶重1-2g。
3、一种制备如权利要求1所述的金银灵芝茶的方法,其特征在于将灵芝草31.59%、金银花10.52%、银杏叶10.52%、麦饭石10.52%、橘皮5.26%、枸杞子5.26%、菊花5.26%、薄菏10.52%、大枣7.90%、甘草2.65%按总重量比为百分之百称量配齐,切成碎块,加50%乙醇浸泡3个小时后,加热回流提取3次,每次1小时,合并滤液,减压回收乙醇,浓缩成稠膏,真空干燥成干浸膏和消毒过的水勾兑成瓶装茶水,每瓶装100-500ml,或将干浸膏与适量泡腾崩解物料用医药加工器械制成泡腾片。
4、一种制备如权利要求1所述的金银灵芝茶的方法,其特征在于将灵芝草31.59%、金银花10.52%、银杏叶10.52%、麦饭石10.52%、橘皮5.26%、枸杞子5.26%、菊花5.26%、薄菏10.52%、大枣7.90%、甘草2.65%按总重量比为百分之百称量配齐,炮制合格,切成碎块,加入适量水共置于容器内用文火熬制3个小时后,将药液取出,静置沉淀、过滤、消毒和适量蜂蜜、糖配制成口服液,瓶或安瓿装,瓶装每瓶100-500ml,安瓿装每支10-15ml。
5、一种制备如权利要求1所述的金银灵芝茶的方法,其特征在于将灵芝草31.59%、金银花10.52%、银杏叶10.52%、麦饭石10.52%、橘皮5.26%、枸杞子5.26%、菊花5.26%、薄菏10.52%、大枣7.90%、甘草2.65%,按总重量比为百分之百称量配齐,炮制合格,低温烘焙或晾干,利用气流粉碎器,流能磨或胶体磨将上述药物粉碎成Φ1-5μm的微粉,用医药加工器械制成胶囊或片、丸。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02102121 CN1238007C (zh) | 2002-01-09 | 2002-01-09 | 金银灵芝茶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02102121 CN1238007C (zh) | 2002-01-09 | 2002-01-09 | 金银灵芝茶及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1432404A CN1432404A (zh) | 2003-07-30 |
CN1238007C true CN1238007C (zh) | 2006-01-25 |
Family
ID=27627464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02102121 Expired - Fee Related CN1238007C (zh) | 2002-01-09 | 2002-01-09 | 金银灵芝茶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1238007C (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1915050B (zh) * | 2006-08-31 | 2010-05-12 | 王学清 | 灵芝茶及其加工工艺 |
CN101919464B (zh) * | 2010-09-14 | 2012-10-10 | 福建岁昌生态农业开发有限公司 | 灵芝复合茶饮料的生产工艺 |
CN102742708B (zh) * | 2012-07-30 | 2013-10-30 | 谢宁 | 一种枸杞雪菊保健泡腾茶 |
CN103815086A (zh) * | 2012-11-16 | 2014-05-28 | 郭天伊 | 一种灵芝保健茶的制备方法 |
CN104054870A (zh) * | 2014-06-09 | 2014-09-24 | 梁德政 | 一种以甘蔗为主要原料的茶制品 |
CN104970358A (zh) * | 2015-06-19 | 2015-10-14 | 卢雨萍 | 一种治疗清肝明目的食疗配方及其制备方法 |
CN105558180A (zh) * | 2015-12-10 | 2016-05-11 | 厦门市卫立康保健服务有限公司 | 一种南非叶抗老化养生茶配方 |
CN111904994B (zh) * | 2019-05-07 | 2022-05-06 | 广州王老吉药业股份有限公司 | 中药组合物在制备防治神经退行性疾病的药品中的应用 |
-
2002
- 2002-01-09 CN CN 02102121 patent/CN1238007C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1432404A (zh) | 2003-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103719423A (zh) | 一种灵芝茶及其制备方法 | |
CN104982599A (zh) | 一种植物凉茶浓缩液及低糖植物凉茶饮料 | |
CN111956753B (zh) | 一种药食同源的中药组合物及其制备方法和应用 | |
CN102258708A (zh) | 一种养生酒及其制备方法 | |
CN103636874A (zh) | 一种金银花火麻茶 | |
CN105079465A (zh) | 一种降低血糖的组合物 | |
CN106551056A (zh) | 一种金莲花凉茶固体饮料及其制备方法 | |
CN105454963B (zh) | 无添加食用糖和化学添加剂的全植物型饮料及其制备方法 | |
CN1238007C (zh) | 金银灵芝茶及其制备方法 | |
CN112167574A (zh) | 一种新鲜龟苓膏及其制备方法 | |
CN106343091A (zh) | 一种减肥瘦身茶凉茶饮料及其制备方法 | |
KR102436045B1 (ko) | 생약재 미네랄 효모 발효액을 이용하여 제조되는 발효 흑삼 조성물 및 그 제조방법 | |
CN105194421A (zh) | 一种夏枯草降血脂保健口服液及其制备方法 | |
CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN104383412A (zh) | 解郁养生中药酒及制备方法 | |
CN107998240A (zh) | 一种提神醒脑缓解疲劳清咽保健含片的配方及其制备方法 | |
CN103749839A (zh) | 一种灵芝万寿果茶 | |
CN108522764B (zh) | 一种保健凉茶及其制备方法 | |
CN106173714A (zh) | 一种护肝养胃的饮料及其制备方法 | |
CN110916036A (zh) | 一种佐酒露及其制备方法 | |
CN105981853A (zh) | 一种营养功能丰富的温和的暖茶饮料配方 | |
KR101058422B1 (ko) | 한방 건강 보조 식품 및 그의 제조방법 | |
CN108684992A (zh) | 一种能快速醒酒的植物配方的解酒饮料及其制备方法 | |
CN1044965C (zh) | 沙梨保健饮料 | |
CN102138593A (zh) | 荷叶消脂健美茶的配方 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |